A detailed history of Utah Retirement Systems transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Utah Retirement Systems holds 4,800 shares of RARE stock, worth $210,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,800
Holding current value
$210,000
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.21 - $59.36 $193,008 - $284,928
4,800 New
4,800 $266,000
Q4 2023

Feb 14, 2024

BUY
$31.73 - $49.19 $136,439 - $211,517
4,300 New
4,300 $205,000
Q3 2021

Nov 16, 2021

BUY
$77.92 - $102.4 $7,792 - $10,240
100 Added 3.03%
3,400 $307,000
Q2 2021

Aug 16, 2021

BUY
$92.19 - $115.71 $304,227 - $381,843
3,300 New
3,300 $315,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.06B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.